Pluripotent Stem Cell Purification via Chimera Selection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for establishing stem cells capable of forming chimeras, such as iPS or ES cells, often result in heterogeneous cell populations with a low success rate for organ formation and chimeric embryo preparation, as they fail to effectively remove cells incapable of forming chimeras, leading to inefficient organ anlagen or chimeric animal production.
Innovation Solution
A method involving coculture and reestablishment of pluripotent stem cells between different species using high-quality stem cells, where iPS or ES cells are cocultured with host embryos to select and clone stem cells capable of forming chimeras, followed by repeated cycles to refine the cell population, ensuring high-quality stem cells for organ formation and chimeric embryo creation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If gene transfection or medium modification is used to establish iPS or ES cells, then the ratio of cells capable of forming chimeras is increased, but the cell population remains heterogeneous and contains cells incapable of forming chimeras
Solution Approach 1:
The invention extracts and removes cells incapable of forming chimeras from the heterogeneous cell population through selective transplantation into blastocysts. Only cells with genuine chimera-forming capability can successfully contribute to chimeric embryos, thereby purifying the cell population while maintaining high reliability for chimera formation.
Solution Approach 2:
The invention performs preliminary screening by transplanting candidate cells into blastocysts before final selection. This preliminary action allows early identification and removal of cells that cannot form chimeras, preventing them from contaminating the final high-quality cell population.
2Ease of manufacture
If conventional methods are used to establish iPS or ES cells, then cell establishment is achieved, but the success rate for organ formation and chimeric embryo preparation is low
Solution Approach 1:
The invention implements a feedback mechanism where the outcome of blastocyst transplantation (successful chimera formation or failure) feeds back into the cell selection process. Cells that successfully contribute to chimeric embryos are identified and selected for further use, while failures lead to removal of those cell types, continuously improving the success rate for organ formation.
Solution Approach 2:
The blastocyst transplantation system serves as a self-selecting mechanism where only cells with genuine chimera-forming capability can survive and contribute to chimeric embryos. The biological system itself performs the selection function, automatically filtering out incompetent cells without requiring external intervention.
3Ease of manufacture
If heterogeneous cell populations are used for chimeric embryo preparation, then cell establishment is simplified, but the efficiency of chimeric animal production is reduced
Solution Approach 1:
The invention extracts incompetent cells from the heterogeneous population through selective transplantation. By removing cells that cannot form chimeras, the remaining population achieves high efficiency for chimeric animal production while the initial establishment process remains relatively simple.
Solution Approach 2:
The invention performs preliminary purification of the cell population through blastocyst transplantation before final chimeric animal production. This preliminary action removes inefficient cells early in the process, ensuring that only high-efficiency cells proceed to chimeric animal generation.
Data Source
AI summary
The present application relates to a method for reestablishing stem cells capable of forming chimeras, and cells obtained by the method. The method of the present invention is a technique for monocloning stem cells, for example, capable of forming chimeras from a heterogeneous cell population to obtain high-quality stem cells.